ロード中...
FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer
Retention of androgen receptor (AR) signalling in castrate-resistant prostate cancer (CRPC) highlights the requirement for the development of more effective AR targeting therapies. A key mechanism of resistance to anti-androgens is through expression of constitutively active AR variants (AR-Vs) that...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4745762/ https://ncbi.nlm.nih.gov/pubmed/26336819 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|